The Good Clinical Practice guideline: a bronze standard for clinical research

被引：114

作者：

Grimes, DA

Hubacher, D

Nanda, K

Schulz, KF

Moher, D

Altman, DG

机构：

[1] Family Hlth Int, Res Triangle Pk, NC 27709 USA

[2] Childrens Hosp Eastern Ontario, Res Inst, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada

[3] Inst Hlth Sci, Ctr Stat Med, Oxford, England

来源：

LANCET | 2005年 / 366卷 / 9480期

关键词：

D O I：

10.1016/S0140-6736(05)66875-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：172 / 174

页数：3

共 23 条

[1] Trading risks for markets: the international harmonisation of pharmaceuticals regulation [J].

Abraham, J ;

Reed, T .

HEALTH RISK & SOCIETY, 2001, 3 (01) :113-128

[2]

*AC MED SCI, EUR CLIN TRIAL DIR

[3]

[Anonymous], 2003, LANCET, V361, P2167

[4]

[Anonymous], INT C HARM TECHN REQ

[5]

[Anonymous], 2000, INT C HARM TECHN REQ

[6]

[Anonymous], 2001, SIGN 50 GUID DEV HDB

[7]

Blumberg N, 1999, ARCH PATHOL LAB MED, V123, P580

[8]

Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.0.CO

[9]

2-O

[10]

Dixon J R Jr, 1998, Qual Assur, V6, P65

← 1 2 3 →